IP Library Granted Patent US 12,434,032
Granted Patent B2
US 12,434,032 · App. 18/605,641 · Granted Oct 7, 2025

Oxygen gas concentrator with outlet accumulator

Inventor: Todd Allum (Livermore, CA)
Assignee: Inogen, Inc.
A61M16/101A61M16/0672A61M16/106A61M39/24B01D53/053C01B13/0259A61M16/00A61M2016/0027A61M2016/003A61M16/0057A61M2016/1025A61M16/107A61M16/201A61M16/208A61M2205/3331A61M2205/3334A61M2205/50B01D2221/10B01D2253/108B01D2256/12B01D2257/102B01D2258/06B01D2259/402B01D2259/4533B01D2259/4541
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,434,032
App. No.
18/605,641
Granted
Oct 7, 2025
Kind
B2
Abstract

An oxygen concentrator comprises a product tank that is fluidly coupled to at least one sieve bed, and a product gas accumulator tank that is fluidly coupled to the product tank via a first conduit and to an outlet port via a second conduit, wherein the first conduit and the second conduit are disposed to allow at least a portion of product gas to flow from the product tank to the outlet port.

Claims (42)

1. A method of providing oxygen therapy to a patient, the method comprising:

delivering oxygen-enriched gas from at least one sieve bed of an oxygen concentrator to a product tank of the oxygen concentrator;

regulating, with a pressure regulator of the oxygen concentrator arranged downstream of the product tank, pressure of the oxygen-enriched gas from a product tank pressure to a target delivery pressure;

delivering said oxygen-enriched gas at said target delivery pressure to an accumulator tank of the oxygen concentrator, said accumulator tank arranged downstream of both of the product tank and the pressure regulator of the oxygen concentrator;

delivering said oxygen-enriched gas at said target delivery pressure from said accumulator tank to an outlet port of the oxygen concentrator; and

storing, with the accumulator tank, a quantity of the oxygen-enriched gas received from the product tank between each of a plurality of patient inspiratory efforts and supplying the stored oxygen-enriched gas to the outlet port during the plurality of patient inspiratory efforts.

2. The method of claim 1 , wherein the target delivery pressure is associated with a maximum inlet pressure of a patient delivery device in communication with the outlet port of the oxygen concentrator.

3. The method of claim 1 , wherein:

the oxygen concentrator further comprises:

a flow measurement device arranged between the product tank and the accumulator tank and configured to measure flow of the oxygen-enriched gas; and

a controller; and

the method further comprises:

receiving, with the controller, one or more flow measurements from the flow measurement device; and

controlling, using the controller, flow from the product tank to the accumulator tank at least partly based on said one or more flow measurements.

4. The method of claim 1 , further comprising delivering the oxygen-enriched gas to the patient using a nasal interface.

5. The method of claim 1 , wherein said supplying the stored oxygen-enriched gas to the outlet port during the plurality of patient inspiratory efforts comprises supplying the stored oxygen-enriched gas to the outlet port at a consistent flow rate during the plurality of patient inspiratory efforts.

6. A method of providing oxygen therapy to a patient, the method comprising:

delivering oxygen-enriched gas from at least one sieve bed of an oxygen concentrator to a product tank of the oxygen concentrator;

regulating, with a pressure regulator of the oxygen concentrator arranged downstream of the product tank, pressure of the oxygen-enriched gas from a product tank pressure to a target delivery pressure;

delivering said oxygen-enriched gas at said target delivery pressure to an accumulator tank of the oxygen concentrator, said accumulator tank arranged downstream of both of the product tank and the pressure regulator of the oxygen concentrator; and

delivering said oxygen-enriched gas at said target delivery pressure from said accumulator tank to an outlet port of the oxygen concentrator, said outlet port configured to be connected to a patient delivery device.

7. The method of claim 6 , wherein:

the oxygen concentrator further comprises:

a flow measurement device arranged between the product tank and the accumulator tank and configured to measure flow of the oxygen-enriched gas; and

a controller; and

the method further comprises:

receiving, with the controller, one or more flow measurements from the flow measurement device; and

controlling, using the controller, flow from the product tank to the accumulator tank at least partly based on said one or more flow measurements.

8. The method of claim 6 , wherein said patient delivery device comprises a nasal interface, and wherein the method further comprises delivering the oxygen-enriched gas to the patient using the nasal interface.

9. The method of claim 6 , further comprising filtering the oxygen-enriched gas.

10. A method of providing oxygen therapy to a patient, the method comprising:

delivering oxygen-enriched gas to a product tank of an oxygen concentrator;

determining, using a tank pressure measurement device of the oxygen concentrator, one or more pressure measurements of the oxygen-enriched gas in the product tank;

regulating, with a pressure regulator of the oxygen concentrator, pressure of the oxygen-enriched gas from a product tank pressure to a target delivery pressure based at least partly on the one or more pressure measurements, said pressure regulator arranged downstream of the product tank;

delivering said oxygen-enriched gas at said target delivery pressure to an accumulator tank of the oxygen concentrator, said accumulator tank arranged downstream of both of the product tank and the pressure regulator of the oxygen concentrator;

determining, using a flow measurement device of the oxygen concentrator, one or more flow measurements of the oxygen-enriched gas flowing from the product tank to the accumulator tank;

controlling delivery of the oxygen-enriched gas to the accumulator tank of the oxygen concentrator based at least partly on said one or more flow measurements; and

delivering said oxygen-enriched gas from said accumulator tank to an outlet port of the oxygen concentrator, said outlet port configured to be connected to a patient delivery device.

11. The method of claim 10 , wherein said patient delivery device comprises a nasal interface, and wherein the method further comprises delivering the oxygen-enriched gas to the patient using the nasal interface.

12. The method of claim 10 , wherein said delivering the oxygen-enriched gas to the outlet port comprises supplying oxygen-enriched gas stored in the accumulator tank to the outlet port at a consistent flow rate during a plurality of patient inspiratory efforts.

13. The method of claim 10 , further comprising storing, with the accumulator tank, a quantity of the oxygen-enriched gas received from the product tank between each of a plurality of patient inspiratory efforts and supplying the stored oxygen-enriched gas to the outlet port during the plurality of patient inspiratory efforts.

14. The method of claim 10 , wherein the target delivery pressure is associated with a maximum inlet pressure of the patient delivery device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2024
From: ALLUM, TODD
To: SILVERBOW DEVELOPMENT, LLC
Reel/Frame 067970/0159 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2024
From: SILVERBOW DEVELOPMENT, LLC
To: INOGEN, INC.
Reel/Frame 067970/0162 →
Continuity (5)
Division 17063708 · Oct 5, 2020
Continuation 15706616 · Sep 15, 2017
Continuation 15603380 · May 23, 2017
Provisional Application 62341021 · May 24, 2016
Related Publication 20240216636A1 · Jul 4, 2024
References Cited (25)
US 4983190A · Verrando et al. · 1991 [cited by applicant]
US 5578115A · Cole · 1996 [cited by applicant]
US 5720276A · Kobatake et al. · 1998 [cited by applicant]
US 6302107B1 · Richey · 2001 [cited by applicant]
US 10792453B2 · Allum et al. · 2020 [cited by applicant]
US 11964105B2 · Allum et al. · 2024 [cited by applicant]
US 20020038656A1 · Yagi et al. · 2002 [cited by applicant]
US 20020053286A1 · Czabala · 2002 [cited by applicant]
US 20040079359A1 · Aylsworth et al. · 2004 [cited by applicant]
US 20060174881A1 · Jagger et al. · 2006 [cited by applicant]
US 20080135044A1 · Freitag et al. · 2008 [cited by applicant]
US 20080178881A1 · Whitcher et al. · 2008 [cited by applicant]
US 20090293879A1 · Fraanberg · 2009 [cited by applicant]
US 20120272966A1 · Ando et al. · 2012 [cited by applicant]
US 20130025591A1 · Clark et al. · 2013 [cited by applicant]
US 20130205997A1 · Sommier et al. · 2013 [cited by applicant]
US 20140137744A1 · Wilkinson et al. · 2014 [cited by applicant]
US 20150107585A1 · Allum · 2015 [cited by applicant]
US 20150196727A1 · Ahmad · 2015 [cited by applicant]
US 20160279362A1 · Devries et al. · 2016 [cited by applicant]
US 20160310886A1 · Von · 2016 [cited by applicant]
US 20170072159A1 · Romano · 2017 [cited by examiner]
US 20170340851A1 · Allum et al. · 2017 [cited by applicant]
US 20190134340A1 · Nebrigac · 2019 [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2017/034332 dated Sep. 21, 2017, 20 pages. [cited by applicant]